CHINA RISUN GP (01907) releases annual performance, with a net profit attributable to shareholders of 58.08 million yuan, a year-on-year increase of 188.12%.
China Xuyang Group (01907) released its annual performance results for the year ended December 31, 2025. The Group achieved revenue of 39.286 billion yuan; the company's net profit attributable to owners reached 58.008 million yuan, an increase of 188.12% year-on-year; basic earnings per share were 0.013 yuan. It is proposed to distribute a final dividend of 0.19 yuan per share.
CHINA RISUN GP (01907) announced its annual performance for the year ended December 31, 2025. The group achieved revenue of 39.286 billion yuan; the profit attributable to owners of the company was 58.08 million yuan, an increase of 188.12% year-on-year; basic earnings per share were 0.013 yuan. It is proposed to declare a final dividend of 0.19 yuan per share.
The announcement stated that in the current year, the new Pingxiang production park with an annual production capacity of 1.8 million tons of coke in Pingxiang City, Jiangxi Province has been completed and put into operation. The new production park is equipped with two 65-hole 6.78m stamping coke ovens, coal coking systems, coal gas purification systems, auxiliary production facilities, and a 260 tons per hour dry quenching coke and ultra-high pressure steam turbine generator set. The group uses advanced equipment and technology in coke stamping and other areas, making Pingxiang one of the most automated coke oven production facilities in China.
The group currently operates 9 production parks globally, with eight located in three provinces and one autonomous region in China, and the ninth located in Sulawesi, Indonesia. In the current year, a new production park in Pingxiang, Jiangxi Province has also begun production. The group's main expansion concept is to increase the annual production and processing volume of coke and fine chemical products according to the market and the group's own five-year plan. With new production facilities gradually coming into operation, the group's overall production capacity is expected to further increase. This allows the group to expand its production chain, offering 58 coke, fine chemicals, and hydrogen products. In the long run, the group will strive to maintain its leading position in the coke, fine chemical, and hydrogen product industries, and continue to create sustainable value for shareholders.
Related Articles

INSILICO (03696) reached global pipeline authorization and AI drug development cooperation with Roche.

JIANGSU EXPRESS (00177) has announced its performance for 2025, with a net profit attributable to shareholders of approximately RMB 4.594 billion, representing a year-on-year decrease of about 7.13%.

New Stock News | Aqara International Ltd. Submits Application to Hong Kong Stock Exchange
INSILICO (03696) reached global pipeline authorization and AI drug development cooperation with Roche.

JIANGSU EXPRESS (00177) has announced its performance for 2025, with a net profit attributable to shareholders of approximately RMB 4.594 billion, representing a year-on-year decrease of about 7.13%.

New Stock News | Aqara International Ltd. Submits Application to Hong Kong Stock Exchange

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


